Optimark and cardiac arrest Patient Reports February 09, 2010

Optimark Side Effects Report #5390885-7
Optimark side effect was reported by a Physician from UNITED STATES on June 29, 2007. Male patient, 14 years of age, was diagnosed with nuclear magnetic resonance imaging brain and was treated with Optimark. After drug was administered, patient experienced the following side effects: bradycardia, cachexia, calcinosis, cardiac arrest , cardiac failure, cardiomegaly, continuous haemodiafiltration, diaphragmatic disorder, discomfort. Optimark dosage: 9 ML, SINGLE. During the same period patient was treated with PROHANCE, OMNISCAN, MAGNEVIST, VINCRISTINE, DACTINOMYCIN, CYCLOPHOSPHAMIDE, IFOSFAMIDE. Patient was hospitalized and became disabled. Patient died.

Optimark Side Effects Report #5728706-2
Optimark side effect was reported by a Health Professional from GERMANY on Apr 21, 2008. Female patient was diagnosed with nuclear magnetic resonance imaging brain and was treated with Optimark. After drug was administered, patient experienced the following side effects: cardiac arrest , nephrogenic systemic fibrosis. Optimark dosage: 9 ML, SINGLE. During the same period patient was treated with PROHANCE, OMNISCAN. Patient was hospitalized and became disabled. Patient died on 01/17/2005.

Optimark Side Effects Report #5849580-X
Optimark side effect was reported by a Health Professional from UNITED STATES on Aug 11, 2008. Female patient was diagnosed with nuclear magnetic resonance imaging brain and was treated with Optimark. After drug was administered, patient experienced the following side effects: cardiac arrest , nephrogenic systemic fibrosis. Optimark dosage: 9 ML, SINGLE. During the same period patient was treated with PROHANCE, OMNISCAN. Patient was hospitalized and became disabled. Patient died on 01/17/2005.

Optimark Side Effects Report #5853838-8
Optimark side effect was reported by a Health Professional from UNITED STATES on Aug 12, 2008. Female patient was diagnosed with nuclear magnetic resonance imaging brain and was treated with Optimark. After drug was administered, patient experienced the following side effects: cardiac arrest , nephrogenic systemic fibrosis. Optimark dosage: 9 ML, SINGLE. During the same period patient was treated with PROHANCE, OMNISCAN. Patient was hospitalized and became disabled. Patient died on 01/17/2005.